| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1043850751 |
| P356 | DOI | 10.1038/KI.2011.341 |
| P3181 | OpenCitations bibliographic resource ID | 634324 |
| P698 | PubMed publication ID | 21975860 |
| P5875 | ResearchGate publication ID | 51695943 |
| P50 | author | Jeff S Coombes | Q60994552 |
| P2093 | author name string | Robert G Fassett | |
| P2860 | cites work | Antioxidants prevent health-promoting effects of physical exercise in humans | Q24646248 |
| Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients | Q27863446 | ||
| Role of oxidative modifications in atherosclerosis | Q29617974 | ||
| Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients. | Q30840532 | ||
| Vitamin E, lipid profile, and peroxidation in hemodialysis patients. | Q31905827 | ||
| Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy | Q32067820 | ||
| Time course and dose response of alpha tocopherol on oxidative stress in haemodialysis patients | Q33511679 | ||
| MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q33960122 | ||
| Rosuvastatin and cardiovascular events in patients undergoing hemodialysis | Q34016806 | ||
| Effect of dialysis dose and membrane flux in maintenance hemodialysis | Q34165823 | ||
| Vitamin E consumption and the risk of coronary heart disease in men. | Q34363912 | ||
| Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. | Q34568927 | ||
| The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia | Q34952514 | ||
| Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland | Q36140573 | ||
| Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study | Q36743855 | ||
| Reactive oxygen species in living systems: source, biochemistry, and role in human disease | Q37413721 | ||
| Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus | Q37728774 | ||
| Oxidative stress biomarkers as predictors of cardiovascular disease. | Q37791726 | ||
| Resveratrol and cellular mechanisms of cancer prevention | Q37831924 | ||
| Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease | Q37831940 | ||
| Effect of vitamin C and zinc on osmotic fragility and lipid peroxidation in zinc-deficient haemodialysis patients | Q40583558 | ||
| Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. | Q40897625 | ||
| Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients | Q42660443 | ||
| Increased monocyte adhesion-promoting capacity of plasma in end-stage renal disease – response to antioxidant therapy | Q42875167 | ||
| Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients. | Q43038941 | ||
| Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis. | Q43063227 | ||
| Elevated plasma F2-isoprostanes in patients on long-term hemodialysis | Q43586164 | ||
| Homocysteine and lipid peroxidation in haemodialysis: role of folinic acid and vitamin E. | Q43781566 | ||
| Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients | Q43797471 | ||
| Antioxidants and atherosclerosis: don't throw out the baby with the bath water | Q44324608 | ||
| Serum vitamin E and oxidative protein modification in hemodialysis: a randomized clinical trial | Q80692581 | ||
| Reduced glomerular filtration rate, inflammation and HDL cholesterol as main determinants of superoxide production in non-dialysis chronic kidney disease patients | Q83764108 | ||
| Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD | Q83917014 | ||
| Vitamin E supplementation | Q93964751 | ||
| Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker | Q94701612 | ||
| The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial | Q44324616 | ||
| Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure | Q44358751 | ||
| Effect of ascorbic acid administration in hemodialysis patients on in vitro oxidative stress parameters: influence of serum ferritin levels | Q44493986 | ||
| N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients--a pilot study. | Q44496423 | ||
| N-acetylcysteine improves nitric oxide and alpha-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats | Q44506114 | ||
| Effects of vitamin supplementation on microcirculatory disturbance in hemodialysis patients without peripheral arterial disease. | Q44520013 | ||
| Vitamin E supplementation increases LDL resistance to ex vivo oxidation in hemodialysis patients | Q44571144 | ||
| Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end-stage renal disease patients. | Q44631288 | ||
| The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients | Q44668759 | ||
| Protective effect of vitamin C on 8-hydroxy-2'-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients | Q44978390 | ||
| Pro-oxidative effect of alpha-tocopherol in the oxidation of LDL isolated from co-antioxidant-depleted non-diabetic hemodialysis patients | Q45068353 | ||
| Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress | Q45165519 | ||
| Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease. | Q46035400 | ||
| Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein concentration [LDL(-)] in haemodialysis patients. | Q46142304 | ||
| Lipoperoxidation and hemodialysis | Q46357343 | ||
| Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. | Q46405188 | ||
| Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial | Q46442488 | ||
| Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients | Q46570325 | ||
| Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis | Q46610834 | ||
| Effect of ascorbic acid supplementation on plasma isoprostanes in haemodialysis patients. | Q46735408 | ||
| Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients. | Q50653249 | ||
| Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. | Q51052485 | ||
| A randomized, controlled trial of early versus late initiation of dialysis. | Q51685434 | ||
| Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. | Q53532398 | ||
| Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study. | Q53579779 | ||
| Influence of Oral Vitamin E Therapy on Micro-Inflammation and Cardiovascular Disease Markers in Chronic Hemodialysis Patients | Q57825359 | ||
| Influence of Parenteral Iron Therapy and Oral Vitamin E Supplementation on Neutrophil Respiratory Burst in Chronic Hemodialysis Patients | Q57825408 | ||
| The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C. | Q64979618 | ||
| Platelet lipid peroxidation in haemodialysis patients: effects of vitamin E supplementation | Q69274816 | ||
| Relationship between red blood cell lipid peroxidation, plasma hemoglobin, and red blood cell osmotic resistance before and after vitamin E supplementation in hemodialysis patients | Q69585551 | ||
| N-acetylcysteine increases the glutathione content and protects rat alveolar type II cells against paraquat-induced cytotoxicity | Q70991275 | ||
| Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) | Q71060539 | ||
| Advanced oxidation protein products as a novel marker of oxidative stress in uremia | Q71324551 | ||
| Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patients | Q71574897 | ||
| Protective effects of antioxidants against uraemia-induced lipid peroxidation and glutathione depletion in humans | Q71602558 | ||
| Reversal of selenium and zinc deficiencies in chronic hemodialysis patients by intravenous sodium selenite and zinc gluconate supplementation. Time-course of glutathione peroxidase repletion and lipid peroxidation decrease | Q71611293 | ||
| Protein oxidation in hemodialysis and kidney transplantation | Q71807974 | ||
| Abnormal antioxidant vitamin and carotenoid status in chronic renal failure | Q71835614 | ||
| Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial | Q73176018 | ||
| Plasma protein thiol oxidation and carbonyl formation in chronic renal failure | Q73293282 | ||
| Vitamin E supplementation and cardiovascular events in high-risk patients | Q73365511 | ||
| Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis | Q73400195 | ||
| Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy | Q73712824 | ||
| Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation | Q73932786 | ||
| Vitamin C and E supplements improve the impaired antioxidant status and decrease plasma lipid peroxides in hemodialysis patients small star, filled | Q78844858 | ||
| Cardiovascular diseases and the nitric oxide pathway | Q80472657 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| hemodialysis patient | Q126109077 | ||
| P304 | page(s) | 233-246 | |
| P577 | publication date | 2011-10-05 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Antioxidant therapy in hemodialysis patients: a systematic review | |
| P478 | volume | 81 |
| Q38582633 | A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB. |
| Q50456717 | Ankyrin is the major oxidised protein in erythrocyte membranes from end-stage renal disease patients on chronic haemodialysis and oxidation is decreased by dialysis and vitamin C supplementation. |
| Q61817225 | Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence? |
| Q37540154 | Associations of GSTM1*0 and GSTA1*A genotypes with the risk of cardiovascular death among hemodialyses patients |
| Q38025185 | Cardiovascular disease in chronic kidney disease: untying the Gordian knot |
| Q38257182 | Chronic kidney disease and premature ageing |
| Q38206770 | Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations. |
| Q42264458 | Direct measurement of reactive oxygen species in leukocytes during hemodialysis therapy |
| Q89249079 | Effectiveness of N-acetylcysteine for preserving residual renal function in patients undergoing maintenance hemodialysis: multicenter randomized clinical trial |
| Q36850302 | Enantiomeric Lignans and Neolignans from Phyllanthus glaucus: Enantioseparation and Their Absolute Configurations |
| Q93199373 | Gum Arabic (Acacia Senegal) Augmented Total Antioxidant Capacity and Reduced C-Reactive Protein among Haemodialysis Patients in Phase II Trial |
| Q33634860 | High-dialysate-glucose-induced oxidative stress and mitochondrial-mediated apoptosis in human peritoneal mesothelial cells |
| Q48677763 | Indices of adrenal deficiency involved in brain plasticity and functional control reorganization in hemodialysis patients with polysulfone membrane: BOLD-fMRI study |
| Q44668427 | Kidney fibrosis is independent of the amount of ascorbic acid in mice with unilateral ureteral obstruction |
| Q47156134 | N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy |
| Q91620789 | N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis |
| Q35524790 | Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients. |
| Q60047016 | Oxidative Stress and Neonatal Respiratory Extracorporeal Membrane Oxygenation |
| Q90284151 | Oxidative Stress in Hemodialysis Pediatric Patients |
| Q85952661 | Oxidative stress contributes to muscle atrophy in chronic kidney disease patients |
| Q38183810 | Oxidative stress during extracorporeal circulation. |
| Q43734669 | Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and E supplementation |
| Q53120047 | Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease. |
| Q57806981 | Protective Role of Histidine Supplementation Against Oxidative Stress Damage in the Management of Anemia of Chronic Kidney Disease |
| Q37604744 | Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial |
| Q53621228 | Serum sulfatide abnormality is associated with increased oxidative stress in hemodialysis patients. |
| Q47112177 | Status of antioxidant and homocysteine-lowering vitamins related to cardiovascular diseases in hemodialysis patients. |
| Q60175931 | The biocompatibility and bioactivity of hemodialysis membranes: their impact in end-stage renal disease |
| Q42427842 | The effect of N-acetylcysteine on oxidative serum biomarkers of hemodialysis patients |
| Q26740125 | Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease |
| Q39251664 | Variability of oxidative stress biomarkers in hemodialysis patients |
| Q37360393 | Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients |
| Q38185736 | Vitamins in dialysis: who, when and how much? |
| Q44916889 | Wishful Thinking: The Surprisingly Sparse Evidence for a Relationship between Oxidative Stress and Cardiovascular Disease in Hemodialysis Patients |
Search more.